PD-1 (Human) Cell Binding Assay, Jurkat/PD-1-based

This assay is used to validate the binding affinity of PD-1 (Human) binding molecules (such as anti-PD-1 antibody, ADC) in a cellular context. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.

Customized to client's specific requirements

Jurkat/PD-1 (Human)

Human

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #NM_005018). Which can be used in binding assays and functional assay.

Jurkat

Cancer

Oncology

In Vitro Cell Binding Assay

Useful for validating the binding affinity of PD-1 (Human) binding molecules (such as anti-PD-1 antibody, ADC) in a cellular context.

Cell-based binding assay is one of most commonly used assays for drug discovery and screening. Creative Biolabs provides In Vitro PD-1 (Human) Cell Binding Assay to validate the binding affinity of 4-1BB (Human) binding molecules (such as anti-4-97BB antibody, ADC) by cell-based ELISA or cell-based FACS analysis. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.

Cell-based Binding Assay; Cell-based ELSA Binding; Cell-based FACS Binding

Cell Binding Assay

Validating the binding affinity of PD-1 (Human) binding molecules (such as anti-PD-1 antibody, ADC) by cell-based ELISA or cell-based FACS analysis.

Creative have developed the stable cell line Jurkat/PD-1 (Human), which is designed for validating the binding affinity of PD-1 (Human) binding molecules (such as anti-PD-1 antibody, ADC) by cell-based ELISA or cell-based FACS analysis.